Impact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020.
PCR
SARS-CoV-2
diagnostics
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
entrez:
18
6
2021
pubmed:
19
6
2021
medline:
24
6
2021
Statut:
ppublish
Résumé
We assessed the impact of COVID-19 on diagnostic services for tuberculosis (TB) by national reference laboratories in the WHO European Region. Of 35 laboratories, 30 reported declines in TB sample numbers, amounting up to > 50% of the pre-COVID-19 volumes. Sixteen reported reagent or consumable shortages. Nineteen reallocated ressources to SARS-CoV-2 testing, resulting in an overall increase in workload, largely without a concomitant increase in personnel (n = 14). This poses a risk to meeting the 2025 milestones of the End TB Strategy.
Identifiants
pubmed: 34142651
doi: 10.2807/1560-7917.ES.2021.26.24.2100426
pmc: PMC8212594
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : FIC NIH HHS
ID : D43 TW007124
Pays : United States
Investigateurs
Ana Avellón
(A)
Zamira Baydulloeva
(Z)
Vladimir Chulanov
(V)
Daniela Maria Cirillo
(DM)
Dmitry Kireev
(D)
Claudio U Köser
(CU)
Stefan Niemann
(S)
Ecaterina Noroc
(E)
Roger Paredes
(R)
Rob Schuurman
(R)
Elina V Sevastyanova
(EV)
Daniel Simões
(D)
Alena Skrahina
(A)
Maja Stanojevic
(M)
Commentaires et corrections
Type : ErratumIn
Références
EClinicalMedicine. 2020 Oct 24;28:100603
pubmed: 33134905
Eur Respir J. 2021 Jan 5;57(1):
pubmed: 33184119
Int J Tuberc Lung Dis. 2021 Mar 1;25(3):167-170
pubmed: 33688804
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32513784
Emerg Infect Dis. 2020 Nov;26(11):2709-2712
pubmed: 32917293
Eur Respir J. 2020 Oct 1;56(4):
pubmed: 32703780
Euro Surveill. 2020 Nov;25(47):
pubmed: 33243354
Emerg Infect Dis. 2020 Nov;26(11):2549-2554
pubmed: 32956612